Department of Surgery, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, USA.
J Surg Oncol. 2010 Mar 15;101(4):315-20. doi: 10.1002/jso.21469.
The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions.
胰腺癌的最佳治疗方法仍在不断发展。新辅助放化疗是当前治疗方案的重要组成部分,对既往治疗方案的评估将有助于指导未来的临床试验。本文作者对当前的文献进行了综述,并讨论了未来的发展方向。